2014
DOI: 10.1902/jop.2014.140198
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Two Differently Processed Acellular Dermal Matrix Products for Root Coverage Procedures: A Prospective, Randomized Multicenter Study

Abstract: Both FDADM and SDADM can be used successfully to correct Miller Class I or II recession defects. There were no statistically significant differences between groups for any of the clinical parameters tested.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
36
0
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 35 publications
(42 citation statements)
references
References 26 publications
4
36
0
1
Order By: Relevance
“…5,6,13 Currently, the ADM is more routinely used for root coverage procedures (Fig. 2), [14][15][16][17][18][19] particularly when avoiding a second surgical site and minimizing patient morbidity is the primary concern. 2), [14][15][16][17][18][19] particularly when avoiding a second surgical site and minimizing patient morbidity is the primary concern.…”
Section: Decellularized Human Dermismentioning
confidence: 99%
“…5,6,13 Currently, the ADM is more routinely used for root coverage procedures (Fig. 2), [14][15][16][17][18][19] particularly when avoiding a second surgical site and minimizing patient morbidity is the primary concern. 2), [14][15][16][17][18][19] particularly when avoiding a second surgical site and minimizing patient morbidity is the primary concern.…”
Section: Decellularized Human Dermismentioning
confidence: 99%
“…With regard to the impact of the graft processing procedure on the final clinical outcomes, it has been evaluated in two studies that were limited to management of isolated gingival recession [45,46]. In both studies, mean root coverage of 71-81% was reported, and the difference between freeze-dried ADM (AlloDerm®) and solventdehydrated ADM (Puros® Dermis, Zimmer) was not statistically significant.…”
Section: Acellular Dermal Matrix Allograftmentioning
confidence: 99%
“…In these defects, it has been suggested that SCTG is the gold standard for treatment, resulting in good clinical outcomes that are stable over time 9,16,20,21 . CAF with enamel matrix derivative (EMD) and ADM with CAF have also shown good clinical outcomes up to 10 years after surgery in Miller Class I and II defects 18,19,31 …”
Section: Discussionmentioning
confidence: 99%
“…Twenty‐five abstracts 2‐4,7,10‐30 were hand reviewed, and seven full articles 10‐13,16,17,29 were reviewed. Four articles 10‐13 are included in this study.…”
Section: Search Outcomementioning
confidence: 99%